Two Sigma Investments »

Tvardi Therapeutics shares owned by Two Sigma Investments

Quarter-by-quarter ownership of Tvardi Therapeutics (TVRD) shares owned by Two Sigma Investments from 13F filings

Historical chart of Two Sigma Investments investment in Tvardi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tvardi Therapeutics held by Two Sigma Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tvardi Therapeutics by Two Sigma Investments

Quarter filed Position value Share count Share price at filing
2025-12-31 $45k 11k 4.30

More positions owned by Two Sigma Investments

NVIDIA Corporation (NVDA)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Tesla Motors (TSLA)
JPMorgan Chase & Co. (JPM)
Palantir Technologies Cl A (PLTR)
Costco Wholesale Corporation (COST)
TJX Companies (TJX)
Mastercard Incorporated Cl A (MA)
Metropcs Communications (TMUS)
Lockheed Martin Corporation (LMT)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Micron Technology (MU)
Adobe Systems Incorporated (ADBE)

View all positions for Two Sigma Investments

Top funds holding Tvardi Therapeutics

Slate Path Capital
Vanguard Group
BlackRock
Vanguard Capital Management
American Financial Group
Geode Capital Management
State Street Corporation
Renaissance Technologies
Silvercrest Asset Management Group
Morgan Stanley
Duncan Williams Asset Management
UBS Group
Northern Trust
Vanguard Fiduciary Trust
Farallon Capital Management

View all funds holding Tvardi Therapeutics